Published in Best Pract Res Clin Haematol on January 01, 2006
Transfusion-transmitted infections. J Transl Med (2007) 1.39
Transfusion-transmitted parasitic infections. Asian J Transfus Sci (2010) 1.27
The Use of Solvent/Detergent Treatment in Pathogen Reduction of Plasma. Transfus Med Hemother (2011) 1.03
Prospects for a novel ultrashort pulsed laser technology for pathogen inactivation. J Biomed Sci (2012) 0.99
Lessons from the aprotinin saga: current perspective on antifibrinolytic therapy in cardiac surgery. J Anesth (2009) 0.96
Purification and characterization of human adrenomedullin binding protein-1. Mol Med (2008) 0.82
Chemical and biological mechanisms of pathogen reduction technologies. Photochem Photobiol (2014) 0.82
Controlled inactivation of recombinant viruses with vitamin B2. J Virol Methods (2007) 0.81
Laboratory Evaluation of the Effectiveness of Pathogen Reduction Procedures for Bacteria. Transfus Med Hemother (2011) 0.81
Viral inactivation in hemotherapy: systematic review on inactivators with action on nucleic acids. Rev Bras Hematol Hemoter (2012) 0.79
The influence of riboflavin photochemistry on plasma coagulation factors. Transfus Apher Sci (2009) 0.79
Inactivation of model viruses suspended in fresh frozen plasma using novel methylene blue based device. Iran J Microbiol (2014) 0.79
Rationale and mechanism for the low photoinactivation rate of bacteria in plasma. Proc Natl Acad Sci U S A (2013) 0.78
Xenotropic Murine Leukemia Virus-Related Virus (XMRV) and the Safety of the Blood Supply. Clin Microbiol Rev (2016) 0.77
Photosensitizing nanoparticles and the modulation of ROS generation. Front Chem (2015) 0.76
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use. Blood Transfus (2016) 0.75
The Effects of Ultraviolet Light and Riboflavin on Inactivation of Viruses and the Quality of Platelet Concentrates at Laboratory Scale. Avicenna J Med Biotechnol (2015) 0.75
MPLEx: a method for simultaneous pathogen inactivation and extraction of samples for multi-omics profiling. Analyst (2017) 0.75
Development of High Hydrostatic Pressure Applied in Pathogen Inactivation for Plasma. PLoS One (2016) 0.75
Pathogen-reduced platelets for the prevention of bleeding. Cochrane Database Syst Rev (2017) 0.75
Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med (1998) 4.69
Current status of solvent/detergent-treated frozen plasma. Transfusion (1998) 2.24
Embryonic-fetal erythroid characteristics of a human leukemic cell line. Proc Natl Acad Sci U S A (1980) 1.90
Non-infectious complications of transfusion therapy. Blood Rev (2001) 1.47
Removal of Yersinia enterocolitica from AS-1 red cells. Transfusion (1992) 1.43
Cytokine generation in stored platelet concentrates. Transfusion (1994) 1.35
hADA3 is required for p53 activity. EMBO J (2001) 1.22
Occurrence of the release reaction during preparation and storage of platelet concentrates. Vox Sang (1981) 1.14
Purified JC virus T and T' proteins differentially interact with the retinoblastoma family of tumor suppressor proteins. Virology (2000) 1.11
Two-dimensional gel electrophoresis and immunoblotting of Campylobacter outer membrane proteins. Infect Immun (1987) 1.05
Senile cardiac amyloidosis associated with homozygosity for a transthyretin variant (ILE-122). J Lab Clin Med (1991) 1.00
Clinical and molecular basis of transfusion-induced immunomodulation: summary of the proceedings of a state-of-the-art conference. Transfus Med Rev (2001) 0.93
Cytokine generation in stored, white cell-reduced, and bacterially contaminated units of red cells. Transfusion (1995) 0.92
Plasma fibronectin level and clinical status in cardiac surgery patients. J Lab Clin Med (1983) 0.88
Letter: Abuse of salt "substitute". N Engl J Med (1975) 0.87
Chemotactic peptide binding by intact neutrophils from human neonates. Pediatr Res (1984) 0.87
Activation in stored platelet concentrates: correlation between membrane expression of P-selectin, glycoprotein IIb/IIIa, and beta-thromboglobulin release. Transfusion (1993) 0.86
Isolation and flow cytometric analysis of T-cell-depleted CD34+ PBPCs. Transfusion (2000) 0.85
The effect of mode of agitation and type of plastic bag on storage characteristics and in vivo kinetics of platelet concentrates. Transfusion (1986) 0.84
Recommended methods for conducting radiolabeled platelet survival studies. Transfusion (1986) 0.83
Role of microaggregate blood filtration in clinical medicine. Transfusion (1984) 0.83
Oxygen-detoxifying enzymes in neutrophils of infants and their mothers. J Lab Clin Med (1980) 0.83
Extended storage of platelets in a new plastic container. II. In vivo response to infusion of platelets stored for 5 days. Transfusion (1985) 0.82
Activation of platelet concentrate during preparation and storage. Blood Cells (1992) 0.82
Ingestion of hydroxyethyl starch by human leukocytes. Transfusion (1986) 0.81
Activation and activity of the superoxide-generating system of neutrophils from human infants. Pediatr Res (1983) 0.81
The cellular and molecular basis of the platelet storage lesion: a symposium summary. Transfusion (1992) 0.80
Effect of mode of agitation on storage of platelet concentrates in PL-732 containers for 5 days. Vox Sang (1983) 0.80
Effects of white cell reduction on the resistance of blood components to bacterial multiplication. Transfusion (1994) 0.80
In vitro characteristics of volume-reduced platelet concentrate stored in syringes. Transfusion (1991) 0.79
Autologous blood perfusion for myocardial protection during coronary angioplasty: a feasibility study. Circulation (1987) 0.79
A prospective, randomized study of the use of platelet concentrates irradiated with ultraviolet-B light in patients with hematologic malignancy. Transfusion (1996) 0.79
Apoptosis in transfusion medicine: of death and dying--is that all there is? Transfusion (2000) 0.79
An in vivo evaluation of microaggregate blood filtration during total hip replacement. Ann Surg (1979) 0.79
Presumed immune thrombocytopenia and carcinoma: report of three cases and review of the literature. Am J Med Sci (1980) 0.78
Breast tumor contamination of PBSC harvests: tumor depletion by positive selection of CD34(+) cells. Cytotherapy (2001) 0.78
Removal of anaphylatoxins C3a and C5a and chemokines interleukin 8 and RANTES by polyester white cell-reduction and plasma filters. Transfusion (1998) 0.78
In vitro characteristics of white cell-reduced single-unit platelet concentrates stored in syringes. Transfusion (1994) 0.78
Topical platelet growth factor therapy: of lotions and potions. Transfusion (2001) 0.78
Plasmodium elongatum from a penguin. Wildl Dis (1968) 0.77
Microaggregate blood filtration in patients with compromised pulmonary function. Transfusion (1982) 0.77
Protein changes occurring during storage of platelet concentrates. A two-dimensional gel electrophoretic analysis. Transfusion (1987) 0.77
Effect of blood transfusion on in vivo levels of plasma fibronectin. J Lab Clin Med (1981) 0.77
Universal pre-storage leukoreduction--A defensible use of hospital resources: the Yale-New Haven Hospital experience. Dev Biol (Basel) (2005) 0.76
Release of beta-thromboglobulin during storage of platelet concentrates. Vox Sang (1981) 0.76
5-day storage of platelet concentrates in CLX containers: effect of type of agitation. Vox Sang (1983) 0.76
Optimal dosing and triggers for prophylactic use of platelet transfusions. Curr Opin Hematol (1999) 0.76
Platelet transfusion practice: time for renewed consensus. Transfusion (1998) 0.76
Activation during preparation and storage of platelet concentrates. Transfusion (1992) 0.75
Non-infectious and non-immunologic complications of blood transfusion. Conn Med (1979) 0.75
In vitro evaluation of a new dual screen microaggregate filter. Transfus Sci (1991) 0.75
Effects of methylene blue-treated plasma on red cells and stored platelet concentrates. Transfusion (1999) 0.75
The official requirements for platelet concentrates. Vox Sang (1998) 0.75
Blood-group-A-like substances in pneumococcal vaccine. Ann Intern Med (1982) 0.75
Stability of red cell antigens during prolonged storage in citrate-phosphate-dextrose and a new preservative solution. Transfusion (1983) 0.75
Glutathione in neutrophils from human infants. Acta Haematol (1983) 0.75
Stability of red cell antigens and plasma coagulation factors stored in new formulation plastic blood containers. Transfusion (1983) 0.75
The effect of solvent/detergent-treated plasma on red cells stored in vitro. Transfusion (1995) 0.75
In vitro function of granulocyte concentrates following passage through an electromechanical infusion pump. Transfusion (1986) 0.75
Platelet concentrates. Influence of different preparative protocols on the in vitro release reaction. Vox Sang (1982) 0.75
Problems with irradiators. Vox Sang (2009) 0.75
In vitro characteristics and in vivo viability of platelets contained in granulocyte-platelet apheresis concentrate. Transfusion (1987) 0.75
Safety and cost-containment data that advocate abbreviated pretransfusion testing. Am J Clin Pathol (1990) 0.75
Neutrophils from human infants exhibit decreased viability. Pediatr Res (1981) 0.75
Effect of pentoxifylline on Wrb antigen. Transfusion (1987) 0.75
Letter: Incidence of unwanted pregnancy in Australia. Med J Aust (1975) 0.75
The status of transfusion medicine science and the role of the American Association of Blood Banks: the journey continues. Transfusion (1998) 0.75
Evaluation of flatbed reciprocal motion agitators for resuspension of stored platelet concentrates. Vox Sang (1985) 0.75
The 24-hour shelf-life of cytapheresis platelet concentrates stored in polyvinyl chloride containers should be extended only with caution. Transfusion (1987) 0.75
Fibronectin: applications to clinical medicine. Crit Rev Clin Lab Sci (1986) 0.75
The effect of solvent/detergent-treated plasma on stored platelet concentrates. Transfusion (1993) 0.75
Effects of environmental warming on blood components dispensed in syringes for neonatal transfusions. J Pediatr (1986) 0.75
Hemolytic anti-hr" (e) detectable solely by an automated polybrene technique. Transfusion (1978) 0.75
Activation of complement by blood transfusion filters. Vox Sang (1983) 0.75
Effect of microaggregate blood filtration on granulocyte concentrates in vitro. Transfusion (1983) 0.75
Platelet collection and transfusion using the fenwal CS-3000 cell separator. Transfusion (1981) 0.75
Subinoculation as a technique in the diagnosis of avian Plasmodium. Avian Dis (1966) 0.75
Clinical and serologic management of patients with methyldopa-induced positive antiglobulin tests. Transfusion (1979) 0.75
The role of the American Association of Blood Banks in international blood banking: a vision for the next 50 years. Transfusion (1996) 0.75
Uptake of extracellular calcium by neonatal neutrophils. J Leukoc Biol (1985) 0.75
Hematopoietic cell therapy and transfusion medicine--carpe diem? Transfusion (1995) 0.75
In vitro changes in platelet function and metabolism following increasing doses of ultraviolet-B irradiation. Transfusion (1993) 0.75
Effect of microaggregate blood filtration on platelet concentrates in vitro. Transfusion (1981) 0.75
Effect of storage conditions on radiolabeling of stored platelet concentrates. Transfusion (1986) 0.75
Fibronectin in liquid and frozen stored blood components. Transfusion (1984) 0.75
Use of an electromechanical infusion pump for transfusion of platelet concentrates. Transfusion (1985) 0.75